SAN FRANCISCO & ATLANTA--(BUSINESS WIRE)--Smisson-Cartledge Biomedical, LLC (SCB) announced today their attendance at the In3 Medical Device Summit in San Francisco, California. SCB has received the U.S. Food and Drug Administration (FDA) market clearance of their ThermaCor 1200 thermal infusion system, the first full range, portable normothermic infusion system. SCB was funded in part by the U.S. Military to bring this state-of-the-art, life-saving technology to our wounded soldiers and civilians suffering traumatic injuries or requiring extensive surgeries.
